Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

FAST enough? The U.K. general public's understanding of stroke.

Bietzk E, Davies R, Floyd A, Lindsay A, Greenstone H, Symonds A, Greenfield S.

Clin Med (Lond). 2012 Oct;12(5):410-5.

2.

NIAID resources for developing new therapies for severe viral infections.

Greenstone H, Spinelli B, Tseng C, Peacock S, Taylor K, Laughlin C.

Antiviral Res. 2008 Apr;78(1):51-9. Epub 2007 Nov 9.

PMID:
18061283
3.

CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion.

Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, Refai D, Martin R, Berger EA, Jacobson S.

Glia. 2005 Nov 15;52(3):252-8.

PMID:
15920733
4.

Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46.

Santoro F, Greenstone HL, Insinga A, Liszewski MK, Atkinson JP, Lusso P, Berger EA.

J Biol Chem. 2003 Jul 11;278(28):25964-9. Epub 2003 Apr 29.

5.

Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function.

Greenstone HL, Santoro F, Lusso P, Berger EA.

J Biol Chem. 2002 Oct 18;277(42):39112-8. Epub 2002 Aug 8.

6.

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Reuter JD, Vivas-Gonzalez BE, Gomez D, Wilson JH, Brandsma JL, Greenstone HL, Rose JK, Roberts A.

J Virol. 2002 Sep;76(17):8900-9. Erratum in: J Virol. 2003 Feb;77(4):2799.

7.

L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

Okun MM, Day PM, Greenstone HL, Booy FP, Lowy DR, Schiller JT, Roden RB.

J Virol. 2001 May;75(9):4332-42.

8.

Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors.

Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, Coates AL.

Dev Med Child Neurol. 2000 Jan;42(1):53-60.

9.

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles.

Rudolf MP, Nieland JD, DaSilva DM, Velders MP, Müller M, Greenstone HL, Schiller JT, Kast WM.

Biol Chem. 1999 Mar;380(3):335-40.

PMID:
10223336
10.

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles.

De Bruijn ML, Greenstone HL, Vermeulen H, Melief CJ, Lowy DR, Schiller JT, Kast WM.

Virology. 1998 Oct 25;250(2):371-6.

11.

Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution.

Booy FP, Roden RB, Greenstone HL, Schiller JT, Trus BL.

J Mol Biol. 1998 Aug 7;281(1):95-106.

PMID:
9680478
12.

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.

Greenstone HL, Nieland JD, de Visser KE, De Bruijn ML, Kirnbauer R, Roden RB, Lowy DR, Kast WM, Schiller JT.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1800-5.

13.

Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution.

Trus BL, Roden RB, Greenstone HL, Vrhel M, Schiller JT, Booy FP.

Nat Struct Biol. 1997 May;4(5):413-20.

PMID:
9145113
14.

Multiple conformational states of the bacteriophage T4 capsid surface lattice induced when expansion occurs without prior cleavage.

Kocsis E, Greenstone HL, Locke EG, Kessel M, Steven AC.

J Struct Biol. 1997 Feb;118(1):73-82.

PMID:
9087916
15.

In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.

Roden RB, Greenstone HL, Kirnbauer R, Booy FP, Jessie J, Lowy DR, Schiller JT.

J Virol. 1996 Sep;70(9):5875-83.

16.

Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Kirnbauer R, Taub J, Greenstone H, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT.

J Virol. 1993 Dec;67(12):6929-36.

18.
19.

Factors associated with cigaret smoking in elementary school children.

West M, Carlin M, Subak M, Greenstone H.

Can Fam Physician. 1983 Apr;29:717-20.

Supplemental Content

Loading ...
Support Center